Green Planet Bioengineering (GPLB) Earnings
Price: $0.11
Market Cap: $2.20M
Market Cap: $2.20M
Revenue (TTM): $-
Net Income: $-35.54K
Net Income: $-35.54K
P/E Ratio: -61.91
EPS (TTM): $0.00
EPS (TTM): $0.00
Earnings Dates
Green Planet Bioengineering (GPLB) reports its earnings quarterly. Here are the key details:
Next Earnings Date
- Date:
- Time of Day:
- Estimated EPS: $N/A
Last Earnings Report
- Date: September 29, 2023
- EPS: $-0.00
- EPS Estimate: $None
Green Planet Bioengineering's next earnings report is scheduled for .
In its last earnings report on September 29, 2023, Green Planet Bioengineering reported earnings per share (EPS) of $-0.00, compared to an estimated EPS of $-. The company reported revenue of $-, compared to an estimated revenue of $-.
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|
Earnings History
| Date | EPS | EPS Estimate | Revenue | Revenue Estimate |
|---|---|---|---|---|
| September 29, 2023 | $0.00 | $ | $- | $- |
| June 29, 2023 | $0.00 | $ | $- | $- |
| March 30, 2023 | $0.00 | $ | $- | $- |
| December 30, 2022 | $0.00 | $ | $- | $- |
Annual Earnings
Annual Revenue
$-
Fiscal Year 2024Annual Net Income
$-35.54K
Fiscal Year 2024Annual EPS
$0.00
Fiscal Year 2024Quarterly Earnings
Revenue
$-
Quarter Ending December 31, 2024Net Income
$-12.79K
Quarter Ending December 31, 2024EPS
$0.00
Quarter Ending December 31, 2024Earnings Metrics
Earnings Yield
-0.33%
Year Ending December 31, 2024P/E Ratio
-303.95
Year Ending December 31, 2024Revenue Per Share
$0.00
Year Ending December 31, 2024Earnings Yield (TTM)
-1.62%
Trailing Twelve MonthsP/E Ratio (TTM)
-61.91
Trailing Twelve MonthsRevenue Per Share (TTM)
$0.00
Trailing Twelve MonthsFrequently Asked Questions
Green Planet Bioengineering's next earnings date is scheduled for . The earnings call is expected to take place .
In its last earnings report on September 29, 2023, Green Planet Bioengineering reported earnings per share (EPS) of $0.00, compared to an estimated EPS of $. The company reported revenue of $-, compared to an estimated revenue of $-.
Green Planet Bioengineering's current Price-to-Earnings (P/E) ratio is -303.95. The trailing twelve months (TTM) P/E ratio is -61.91. The P/E ratio is a valuation metric that compares a company's current share price to its earnings per share (EPS). A higher P/E ratio suggests that investors are expecting higher earnings growth in the future compared to companies with a lower P/E ratio.
For the fiscal year ending December 31, 2024, Green Planet Bioengineering reported total revenue of $- and net income of $-35.54K. This represents a net profit margin of None.
Green Planet Bioengineering's earnings yield is -0.33%. The earnings yield is the inverse of the P/E ratio and represents the percentage of each dollar invested in the stock that was earned by the company.
Green Planet Bioengineering's return on equity (ROE) is 0.00%. ROE is a measure of financial performance calculated by dividing net income by shareholders' equity. It measures how effectively management is using a company's assets to create profits.
Green Planet Bioengineering's gross profit margin is 0.00%. This indicates that for every dollar of revenue, the company retains $0.00 as gross profit after accounting for the cost of goods sold.